Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
May 2008 Marketed Drug Updates and Additions

Brand Name
Generic Name
Other Designation
Leukine (USA), Interberin, Prokine Sargramostim  
Zevalin Ibritumomab tiuxetan IDEC-Y2B8
Sprycel Dasatinib BMS-354825
TheraCIM HR3, TheraCIM h-R3, TheraCIM hR3 (USA), Theraloc (Europe), CIMAher (Latin America) Nimotuzumab YM-1001, OSAG101, h-R3, DE 766
Zofran, Zofran ODT, Zofran Zydis Ondansetron  
Erbitux Cetuximab IMC-C225
Tasigna Nilotinib AMN107, AMN-107
Navelbine Vinorelbine tartrate KW-2307 (Japan)
Zadaxin Thymalfasin  
DepoCyt (USA), DepoCyte (formerly Savedar; Europe); formerly Depo/Ara C Cytarabine (ara-C), cytosine arabinoside DTC-101, NSC 63878
Totect (USA), Savene (Europe) Dexrazoxane  
Abelcet Amphotericin B lipid complex  


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM